Henry Ward Wolff Insider Trading $SNSS Viracta Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Henry Ward Wolff.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Henry Ward Wolff. Henry Ward Wolff is CFO & SVP, Finance in ABGENIX INC ($ABGX) and CFO and Sr. VP, Finance in ABGENIX INC ($ABGX) and Exec VP & CFO in SANGAMO BIOSCIENCES INC ($SGMO) and Director in SUNESIS PHARMACEUTICALS INC ($SNSS) and Director in PORTOLA PHARMACEUTICALS INC ($PTLA) and Director in Calithera Biosciences, Inc. ($CALA).

Henry Ward Wolff in Viracta Therapeutics, Inc.

Trading Symbol: SNSS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Henry Ward Wolff: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jul 01 2020
$SNSS Market Capitalization: $85.18M
$SNSS Previous Close: $4.10

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Henry Ward Wolff in Viracta Therapeutics, Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, ABGX, CALA, PTLA, SGMO, SNSS

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares
Jul 01 2020	SNSS	SUNESIS PHARMACEUT ...	Wolff Henry Ward	Director	Option Exercise	A	0.26	60,000	15,804	60,000
Jul 02 2019	SNSS	SUNESIS PHARMACEUT ...	Wolff Henry Ward	Director	Option Exercise	A	0.73	60,000	43,608	60,000
Jul 03 2018	SNSS	SUNESIS PHARMACEUT ...	Wolff Henry Ward	Director	Option Exercise	A	2.12	6,250	13,250	6,250
Jul 03 2018	SNSS	SUNESIS PHARMACEUT ...	Wolff Henry Ward	Director	Option Exercise	A	6.80	37,500	255,000	37,500

Page: 1